Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Na+/K+-ATPase inhibitors disclosed by Sigma-Tau

May 24, 1996

Medco, Fujisawa to codevelop and comarket adenosine for CABG and AMI

May 24, 1996

Transdermal scopolamine studied in hypertensive patients

May 24, 1996

Update on fenoldopam regulatory submission

May 24, 1996

Progress on endothelin antagonists at Texas Biotechnology

May 24, 1996

More angiotensin II antagonists from Japanese companies

May 24, 1996

ADIR claims compounds for venous insufficiency

May 24, 1996

ADIR claims imidazoline I1 receptor ligands for hypertension

May 24, 1996

Baxter will develop graft system developed by Australian investigators

May 24, 1996

Lilly reports agents for septic shock

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...